Low flow anaesthesia

Reading File
Finding Sources
Finding Sources
Searching PubMed

"low flow anaesthesia" AND "fresh gas flow"

Finding Sources
Finding Sources
Searching PubMed

"low flow anesthesia" AND outcomes

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Searching the Web

low flow anaesthesia classification fresh gas flow thresholds recommendations 2024 2025

Reading Web Page

low flow anaesthesia classification fresh gas flow thresholds advantages disadvantages monitoring

Here is a thorough, exam-ready overview of Low Flow Anaesthesia (LFA).

Low Flow Anaesthesia (LFA)

Definition

LFA refers to any inhalational anaesthetic technique where the fresh gas flow (FGF) is less than the patient's minute ventilation, so that a proportion of exhaled gas is rebreathed after CO2 removal. This requires a circle breathing system with a functioning CO2 absorber.

Classification by Fresh Gas Flow

CategoryFGFRebreathing
High-flow> 4 L/minNegligible (~0%)
Moderate/medium flow2-4 L/minMinor
Low flow< 1-2 L/minSignificant (>50%)
Minimal flow≤ 0.5 L/minMajor
Metabolic/basal flow0.25-0.35 L/minNear-complete
Closed circuitFGF = O2 metabolic demand (~250 mL/min)Complete (100%)
The lower threshold of 250 mL/min is the absolute minimum oxygen requirement for resting metabolic processes in a normothermic adult. This must be delivered as 100% O2.
Definitions vary by source. Miller's Anesthesia (10e) defines low-flow as FGF "far less than minute ventilation" with at least 50% rebreathing, and minimal-flow as ≤ 0.5 L/min.

Prerequisites / Equipment Requirements

  1. Circle breathing system - essential; Mapleson circuits are unsuitable (no CO2 absorber support, wasteful)
  2. Functional CO2 absorber (soda lime / Amsorb) - prevents CO2 rebreathing
  3. Accurate vaporizer - must be calibrated and leak-free
  4. Monitoring (mandatory for safe LFA):
    • Inspired oxygen analyzer (lower alarm at 28-30%)
    • Capnography (end-tidal CO2) - most sensitive indicator of absorber exhaustion
    • Volatile agent analyzer (inspired + expired)
    • Oxygen saturation (SpO2)
    • Airway pressure / minute volume monitoring
    • Disconnection alarms

Advantages

1. Economic

  • Volatile agent consumption reduced by up to 75% versus high-flow
  • Greatest savings occur when FGF drops from 4 L/min to 2 L/min; returns diminish below 1 L/min

2. Environmental / Ecological

  • Reduction of greenhouse gas emissions by up to 90%
  • Volatile agents (sevoflurane, desflurane, isoflurane) and N2O are greenhouse gases and ozone-depleting substances
  • Reduced operating-room pollution and staff exposure, especially to nitrous oxide

3. Physiological / Pulmonary

  • Inspired gases are warmed and humidified by rebreathing - aids mucociliary clearance, body temperature maintenance, reduces airway water loss
  • Improved flow dynamics of inhaled gases
  • Reduction in respiratory heat loss - particularly important in paediatrics and long cases

Disadvantages and Hazards

1. Slow changes in anaesthetic depth

  • When circuit FGF is low, altering the vaporizer dial changes inspired concentration slowly (the "time constant" of the circuit is long)
  • If the volatile agent is switched off at low flow, emergence can take 10-20 minutes as concentration slowly decreases
  • Remedy: temporarily increase FGF to flush/wash in the desired change, then return to low flow

2. Accumulation of unwanted gases

The rebreathed mixture may accumulate:
  • Nitrogen (released from body tissues early in anaesthesia) - can dilute the inspired O2 and cause hypoxia
  • Carbon monoxide (CO) - produced when desiccated CO2 absorbents (especially those containing strong bases like KOH/NaOH) interact with desflurane, isoflurane, or sevoflurane. Risk is highest with absorbents dried out by unused machine left running over a weekend (Monday morning risk). FGF ≥ 5 L/min through the absorber without a patient connected is enough to desiccate it critically.
  • Acetone, methane - metabolic by-products exhaled by patients
  • Potentially interfere with gas monitoring if trifluoromethane accumulates

3. Compound A (Sevoflurane specific)

  • Sevoflurane + CO2 absorbent (base-catalyzed) → Compound A (fluoromethyl-2,2-difluoro-1-[trifluoromethyl] vinyl ether), a nephrotoxic vinyl ether
  • Production is enhanced at: low/closed-circuit FGF, warm or dry absorbent, high sevoflurane concentration, long duration, use of Baralyme (now withdrawn from market)
  • Concentrations of 8-32 ppm are produced at 1 L/min with soda lime
  • Clinical significance: extensive human studies show no nephrotoxicity or renal injury at low-flow concentrations. No adverse renal effects detected in randomized, multicenter trials including patients with pre-existing renal disease
  • Most countries have no FGF restriction for sevoflurane; some clinicians recommend ≥ 2 L/min for procedures lasting more than a few hours (cautious practice only)
  • Rats are susceptible to compound A nephrotoxicity; humans appear not to be, due to absence of the relevant renal enzymatic pathway

4. Hypoxia risk

  • Nitrogen washout from tissues early in anaesthesia dilutes O2 in a closed/near-closed circuit
  • Inspired O2 analyzer is the only reliable protection in the low-pressure section of the machine
  • Inspired O2 alarm must be set at 28-30%

5. Absorber monitoring and CO2 buildup

  • Exhausted absorber causes CO2 rebreathing - capnography (inspiratory CO2 > 0) is the most sensitive indicator
  • Ethyl violet colour change in soda lime is not always reliable (can be photo-inactivated by fluorescent light exposure)

Practical Technique

  1. Induction: Use higher FGF (4-6 L/min) initially to denitrogenate the circuit and the patient, achieve target concentration quickly, and fill the circuit volume
  2. Transition to low flow: After ~10-15 minutes (nitrogen has been washed out, equilibration achieved), reduce FGF to target low-flow rate
  3. Maintenance: Titrate vaporizer dial upward to compensate for agent uptake (vaporizer dial reading will be higher than measured inspired concentration)
  4. Depth changes: Temporarily increase FGF to alter inspired concentration rapidly, then reduce again
  5. Emergence: Increase FGF to flush volatile out of circuit; do NOT turn off the vaporizer at minimal flow and expect rapid emergence
  6. Check absorber: Change soda lime when colour indicates exhaustion, or if inspiratory CO2 rises on capnograph

Monitoring for Safe LFA - Summary

ParameterThreshold / Action
Inspired O2Alarm set at 28-30%; must stay above 21%
End-tidal CO2Normal 35-45 mmHg; rise + inspiratory CO2 > 0 = absorber exhausted
Inspired volatile agentMust be monitored continuously
Peak airway pressure / minute volumeDisconnection alarm set 5 mbar below peak pressure
SpO2Continuous

Closed Circuit Anaesthesia

A fully closed circuit is one where FGF exactly equals the patient's O2 metabolic consumption (~250 mL/min), with complete rebreathing and no gas venting. Volatile agent is added in liquid form or via the vaporizer in precise amounts. It maximizes all advantages of LFA but demands intensive vigilance and is not practical for routine use.

Recent Evidence (PubMed 2024-2026)

A 2026 systematic review and meta-analysis (PMID 42121056, Shaban et al., BMC Anaesthesiol) examined automated end-tidal control vs. manual regulation in low-flow volatile anaesthesia, suggesting automated systems improve the precision and safety of LFA delivery. A 2025 RCT (PMID 40217133, Sen et al.) confirmed that end-tidal controlled LFA significantly reduces volatile agent consumption in elective surgery. A 2024 RCT (PMID 39073338, Kurwe et al.) evaluated real-time oxygen consumption-based versus fixed-flow LFA, examining effects on oxygenation and perfusion.

Key Points Summary

  • LFA = FGF < minute ventilation with ≥ 50% rebreathing; requires circle system + CO2 absorber
  • Benefits: cost savings (up to 75%), environmental (up to 90% fewer emissions), improved humidity/temperature
  • Main hazards: slow depth changes, N2 accumulation/hypoxia, CO production from desiccated absorber, compound A (sevoflurane - not clinically toxic in humans)
  • Monitoring is mandatory: O2 analyzer, capnography, agent analyzer, SpO2, pressure alarms
  • Start at high flow for induction/denitrogenation; transition to low flow after ~10-15 min
  • Closed circuit anaesthesia is the extreme form - maximizes benefits but impractical for routine use
Sources: Miller's Anesthesia 10e (pp. 2332-2333); Barash's Clinical Anesthesia 9e (pp. 1444-1445, 2006-2007); Morgan & Mikhail's Clinical Anesthesiology 7e (p. 313-314)
This is a shared conversation. Sign in to Orris to start your own chat.